Convergence and plasticity of monoaminergic systems in the medial prefrontal cortex during the postnatal period: Implications for the development of psychopathology

Cerebral Cortex

Volumn 10, Issue 10, 2000, Pages 1014-1027

  Benes, F M ^a   Taylor, J B ^a   Cunningham, M C ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR;

BRAIN STEM; CELL INTERACTION; DOPAMINERGIC SYSTEM; DORSAL RAPHE NUCLEUS; ELECTROPHYSIOLOGY; IMMUNOFLUORESCENCE; INTERNEURON; MENTAL DISEASE; MONOAMINERGIC SYSTEM; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NONHUMAN; POSTNATAL DEVELOPMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; PYRIFORM CORTEX; REVIEW; SEROTONINERGIC SYSTEM;

EID: 0033798308     PISSN: 10473211     EISSN: None     Source Type: Journal    
DOI: 10.1093/cercor/10.10.1014     Document Type: Review

References (131)

1. Estimation of nuclear population from microtomic sections
2. GABAA receptor subunit gene expression in human prefrontal cortex: Comparison of schizophrenics and controls
3. Cytoarchitecture of the entorhinal cortex in schizophrenia
4. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics
5. Post-mortem structural analyses of schizophrenic brain. Study designs and the interpretation of data
6. Myelination of cortical-hippocampal relays during late adolescence: Anatomical correlates to the onset of schizophrenia
7. Is there a neuroanatomic basis for schizophrenia?
8. A neurodevelopmental approach to the understanding of schizophrenia and other mental disorders
9. A comparison of pyramidal and nonpyramidal neuron density in anterior cingulate cortex of schizophrenic and manic depressive subjects
10. The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia
11. Biochemical and morphometric studies of the relationship of acetylcholine synthesis and vesicle numbers after stimulation of frog neuromuscular junctions: The effect of a choline-o-acetyltransferase inhibitor
12. Deficits in small interneurons in prefrontal and anterior cingulate cortex of schizophrenic and schizoaffective patients
13. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain
14. Dopamine-immunoreactive axon varicosities form nonrandom contacts with GABA-immunoreactive neurons in rat medial prefrontal cortex
15. Myelination of a key relay zone in the hippocampal formation occurs in human brain during childhood, adolescence and adulthood
16. Differences in the subregional and cellular distribution of GABA(A) receptor binding in the hippocampal formation of schizophrenic brain
17. Upregulation of GABA(A) receptor binding on neurons of prefrontal cortex in schizophrenic subjects
18. Increased interaction of dopamine-immunoreactive varicosities with GABA neurons of rat medial prefrontal cortex occurs during the postweanling period
19. Differential distribution of tyrosine hydroxylase fibers on neuronal subtypes in layer II of anterior cingulate cortex of schizophrenic brain
20. Uncoupling of GABA(A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain
21. Neurotransmitter receptors in frontal cortex of schizophrenics
22. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain
23. Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia
24. I. Serotonin (5-HT) within dopamine reward circuits signals open-field behavior. II. Basis for 5-HT-DA interaction in cocaine dysfunctional behavior
25. Cognitive deficit caused by depletion of dopamine in prefrontal cortex of rhesus monkey
26. Pre- and postnatal ontogeny and characterization of dopaminergic D2, serotonergic S2, and spirodecanone binding sites in rat forebrain
27. Mesocortical dopamine systems: Further electrophysiological and pharmacological characteristics
28. Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression
29. Regulation of hippocampal 5-HT1A receptor gene expression by dexamethasone
30. Prenatal and postnatal development of GABA-accumulating cells in the occipital neocortex of rat
31. Stress and GABAergic transmission: Biochemical and behavioural studies
32. Neurochemical aspects of the ontogenesis of GABAnergic neurons in the rat brain
33. 3H-Flupenthixol binding in post-mortem brains of schizophrenics: Evidence for a selective increase in dopamine D2 receptors
34. Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder
35. Ontogeny of the serotonergic projection of rat neocortex: Transient expression of a dense innervation of primary sensory areas
36. High resolution analysis shows D1 receptor binding on pyramidal and nonpyramidal neurons
37. 1 receptors on nonpyramidal neurons in rat mPFC
38. Development of noradrenergic and dopaminergic receptor systems depends on maturation of their presynaptic nerve terminals in the rat brain
39. The origin and distribution of dopamine-containing afferents to rat frontal cortex
40. Development expression of the GABA-A receptor g1 subunit mRNA in the rat brain
41. D1 and D2 receptor gene expression in the rat frontal cortex: Cellular localization in different classes of efferent neurons
42. First demonstration of highly specific and sensitive antibodies against dopamine
43. Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons
44. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex
45. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetaine: Implications for serotonin-dopamine interactions
46. Dopamine decreases the excitability of layer V pyramidal cells in the rat prefrontal cortex
47. 3H-Muscimol binding sites increased in autopsied brains of chronic schizophrenics
48. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia
49. Pharmacological interactions between serotonin and dopamine on behavior in the squirrel monkey
50. Localization of multiple dopamine receptor subtype mRNAs in human and monkey motor cortex and striatum
51. Serotonin-mediated increase in prefrontal cortex dopamine release: Pharmacological characterization
52. 5-Hydroxytryptamine(2A) serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites
53. Prenatal developmental disturbances in the limbic allocortex in schizophrenics
54. Biochemistry of neurotransmitters in cortical development
55. Linking the family of D2 receptors to neuronal circuits in human brain: Insights into schizophrenia
56. Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia
57. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics
58. Hippocampal noradrenaline and serotonin release over 24 h as measured by the dialysis technique in freely moving rats: Correlation to behavioural activity state, effect of handling and tail-pinch
59. Development of the dopaminergic innervation in the prefrontal cortex of rat
60. Ontogeny of open field activity in rats after neonatal lesioning of the mesocortical dopaminergic projection
61. Morphometric analysis of prefrontal cortical development following neonatal lesioning of the dopaminergic mesocortical projection
62. [3H]MK-801 binding sites in post-mortem brain regions of schizophrenic patients
63. 3H-Spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms
64. Quantitative three-dimensional analysis of the catecholaminergic innervation of identified neurons in the macaque prefrontal cortex
65. Elevation of brain neuroleptic/dopamine receptors in schizophrenia
66. Subpopulations of cortical GABAergic interneurons differ by their expression of D1 and D2 dopamine receptor subtypes
67. The serotonin innervation of the cerebral cortex in the rat - An immunocytochemical analysis
68. General organization of cortical monoamine systems
69. Organization of catecholamine neurons projecting to frontal cortex in the rat
70. Postnatal maturation of the GABAergic system in rat neocortex
71. 3H-Spiperone binding in normal and schizophrenic post-mortem human brain
72. Increased brain dopamine and dopamine receptors in schizophrenia
73. Differential effects of ascending neurons containing dopamine and noradrenaline in the control of spontaneous activity and of evoked responses in the rat prefrontal cortex
74. The electrophysiology of prefrontal serotonin systems: Therapeutic implications for psychosis
75. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia
76. An overview of the mechanism of action on clozapine
77. The dopamine hypothesis of schizophrenia: A review
78. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics
79. Immunocytochemical localization and description of neurons expressing 5-HT-2 receptors in the rat brain
80. 1 receptor in interneurons of macaque prefrontal cortex: Distribution and subcellular localization
81. Schizophrenia: Dopamine D1 receptor sequence is normal, but has DNA polymorphisms
82. Increased dopamine-receptor sensitivity in schizophrenia
83. Ontogeny of GABA and benzodiazepine receptors: Effects of Triton X-100, bromide and muscimol
84. Changes in neurotransmitters during development
85. Local infusion of the serotonin antagonist ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex
86. Excitation of rat prefrontal cortical neurons by dopamine: An in vitro electrophysiological study
87. Distribution of catecholamines and serotonin in the rat cerebral cortex: Absolute levels and relative proportions
88. Modulatory role for biogenic amines in the cerebral cortex: Microiontophoretic studies
89. Opposing effects of dopamine D2 receptor stimulation on the spontaneous and the electrically evoked release of [3H]GABA on rat prefrontal cortex slices
90. Synergism between D1 and D2 dopamine receptors in the inhibition of the evoked release of [3H]GABA in the rat prefrontal cortex
91. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia
92. Stress and the mesocorticolimbic dopamine systems
93. Acute stress enhances the activity of the GABA receptor-gated ion channel in brain
94. Dopamine receptors and transporters in Parkinson's disease and schizophrenia
95. Dopamine D4 receptors elevated in schizophrenia
96. Schizophrenia: Normal sequence in the dopamine D2 receptor region that couples to G-proteins. DNA polymorphisms in D2
97. Ultrastructural features of dopamine axon terminals in the anteromedial and suprarhinal cortex of rat
98. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: Evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons
99. Serotonin (5-HT) induces IPSPs in pyramidal layer cells of rat piriform cortex: Evidence for the involvement of a 5-HT2-activated interneuron
100. Reduced GABA uptake sites in the temporal lobe in schizophrenia
101. Heterogenous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: A laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique
102. 1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: Predominant and extrasynaptic localization in dendritic spines
103. Serotonergic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy
104. Neurotrophic effects of GABA in cultures of embryonic chick brain and retina
105. Monoamines in response and adaptation to stress
106. Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. I. Pharmacological characterization
107. Colocalization of glutamate decarboxylase, tyrosine hydroxylase and serotonin immunoreactivity in rat medial prefrontal cortex
108. Neonatal raphe lesions increase dopamine fibers in prefrontal cortex of adult rats
109. Selective activation of the mesocortical DA system by stress
110. Variation in the ability of neuroleptics to block the inhibitory influence of dopaminergic neurons on the activity of cells in the rat prefrontal cortex
111. 65 immunoreactive puncta on pyramidal and non-pyramidal neurons in hippocampus of schizophrenic brain
112. Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: Potential sites for modulation of mesolimbic dopamine neurons
113. Development of the dopaminergic innervation of the rat cerebral cortex. A light microscopic immunocytochemical study using anti-tyrosine hydroxylase antibodies
114. Ultrastructural double-labelling study of dopamine terminals and GABA-containing neurons in rat anteromedial cortex
115. Ultrastructural double-labelling study of dopamine terminals and GABA-containing neurons in rat anteromedial cortex
116. Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex
117. Postnatal maturation of GABA-immunoreactive neurons of rat medial prefrontal cortex
118. Differential regulation of GABAA and benzodiazepine receptor binding in the hippocampal formation of schizophrenics
119. Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex
120. Schizophrenia: A neural diathesis-stress model
121. Elementary introduction to stereological principles
122. Regulation of serotonin-facilitated dopamine release in vivo: The role of protein kinase A activating transduction mechanisms
123. Implications of normal brain development for the pathogenesis of schizophrenia
124. Tritiated LSD binding in frontal cortex in schizophrenia
125. 1 receptors in prefrontal cortex
126. A subclass of prefrontal g-minobutyric acid axon terminals are selectively altered in schizophrenia
127. Development and characterization of monoclonal antibodies specific to the serotonin 5-HT2A receptor
128. The myelinogenetic cycles of regional maturation of the brain
129. 1 receptor actions in layers V-VI rat prefrontal cortex neurons in vitro: Modulation of dendritic-somatic signal integration
130. Dopamine modulation of membrane and synaptic properties of interneurons in rat cortex